1998
DOI: 10.1002/(sici)1521-3757(19981002)110:19<2811::aid-ange2811>3.0.co;2-i
|View full text |Cite
|
Sign up to set email alerts
|

Enantio- und diastereoselektive Synthese von 2-substituierten 1-Bicyclo[3.1.0]hexanolen

Abstract: Nützliche Zwischenstufen für die organische Synthese sind die optisch aktiven, substituierten bicyclischen Cyclopropanole, die mit gängigen Methoden nur schwer zugänglich sind. Sie können nun aus Oppolzer‐N‐Acylcamphersultamen und [Ti(OiPr)2(η2‐Propen)] mit hoher Enantio‐ und Diastereoselektivität einfach hergestellt werden [Gl. (a)]. R=Alkyl, Alkenyl, Benzyl, Alkoxyalkyl, Alkylsiloxyalkyl.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…Sato et al developed an interesting enantioselective synthesis of bicyclic cyclopropanols from N - acylcamphorsultame derivatives. Enantiomeric excesses in the products were up to >98% (Scheme and Table ) 35 …”
Section: B Ligand Exchange With Alkenesmentioning
confidence: 99%
See 1 more Smart Citation
“…Sato et al developed an interesting enantioselective synthesis of bicyclic cyclopropanols from N - acylcamphorsultame derivatives. Enantiomeric excesses in the products were up to >98% (Scheme and Table ) 35 …”
Section: B Ligand Exchange With Alkenesmentioning
confidence: 99%
“…Sato et al developed an interesting enantioselective synthesis of bicyclic cyclopropanols from N- 11). 230 In view of their versatile new synthesis of dialkylcyclopropylamines from N,N-dialkylcarboxamides by way of titanacyclopropane intermediates generated from Grignard reagents and XTi(Oi-Pr) 3 (X ) Oi-Pr, Me), 207,211 de Meijere et al had also soon turned their attention to the additional synthetic potential of titanacyclopropane intermediates generated by ligand exchange. Their first target in mind was the 3-azabicyclo[3.1.0]hexylamine 67, an essential building block for the commercial antibiotic trovafloxacin.…”
Section: B Ligand Exchange With Alkenesmentioning
confidence: 99%